Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial
| Autor: | Bachet, Jean-Baptiste a, b, *, Hammel, Pascal c, Desramé, Jérôme d, Meurisse, Aurélia e, Chibaudel, Benoist f, André, Thierry g, Debourdeau, Philippe h, Dauba, Jérome i, Lecomte, Thierry j, Seitz, Jean-François k, Tournigand, Christophe l, Aparicio, Thomas m, Meyer, Véronique Guerin n, Taieb, Julien o, Volet, Julien p, Monier, Amandine q, Bonnetain, Franck e, Louvet, Christophe r |
|---|---|
| Zdroj: | In The Lancet Gastroenterology & Hepatology May 2017 2(5):337-346 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|